ProMIS Neurosciences, Inc.
NASDAQ:PMNBiotechnology
-$0.02 today
- Market cap
- $99.36M
- Beta
- -0.22
- P/E (TTM)
- -0.6
- EPS (TTM)
- -$4.62
Volume 0.13M
Average 0.07M
PMN Goodwill
The premium paid for acquisitions above the fair value of the identifiable net assets acquired.
ProMIS Neurosciences, Inc.NASDAQ: PMN
Goodwill · Q2 FY2026 · quarter ended Jun 2026
Goodwill remains negative
Q2 FY2026 goodwill was $0, compared with $0 a year earlier.
Context
- Goodwill amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Goodwill increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Goodwill history
Mixed currencies · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Goodwill | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Goodwill vs competitors
How PMN compares with its peers on the latest reported figures
- PMN's Jun 2026 goodwill of $0 is the highest of the 4 companies compared; the peer median is $0.
- Goodwill amounts to 0.0% of total assets for PMN, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $0 | — | — | 0.0% | |
| Dec 2025 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PMN) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for PMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 · CAD | FY2022 Dec 2022 · CAD | FY2023 Dec 2023 · USD | FY2024 Dec 2024 · USD | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Cash & Equivalents | 21.43M | 10.69M | 12.6M | 13.29M | 6.12M |
| Short-term Investments | 50.69K | 79.89K | 32.36K | 33.05K | 33.75K |
| Net Receivables | 0 | 0 | 78.64K | 78.03K | 36.52K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 768.78K | 768.19K | 228.85K | 47.28K | 70.48K |
| Total Current Assets | 22.4M | 12.56M | 13.62M | 18.91M | 9.18M |
| Property, Plant & Equipment (Net) | 5.91K | 584 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 34.92K | 37.91K | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Assets | 40.83K | 38.49K | 0 | 0 | 0 |
| Total Assets | 22.44M | 12.6M | 13.62M | 18.91M | 9.18M |
| Account Payables | 517.17K | 5.41M | 7.84M | 1.74M | 2.54M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 518.7K | 38.33K | 79.75K |
| Total Current Liabilities | 1.17M | 11.67M | 9.35M | 2.22M | 10.41M |
| Long-term Debt | 4.94M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 9.17M | 3.38M | 516.19K | 204.86K | 29.18K |
| Total Non-current Liabilities | 14.11M | 3.38M | 516.19K | 204.86K | 29.18K |
| Total Liabilities | 15.28M | 15.05M | 9.87M | 2.42M | 10.44M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (78.64M) | (146M) | (93.47M) | (90.69M) | (130.41M) |
| Accumulated OCI | (237.63K) | (355.42K) | (371.18K) | (371.18K) | (371.18K) |
| Other Stockholders Equity | 0 | 946 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 7.16M | (2.45M) | 3.75M | 16.49M | (1.26M) |
| Total Debt | 4.94M | 0 | 0 | 0 | 0 |
| Net Debt | (16.49M) | (10.69M) | (12.6M) | (13.29M) | (6.12M) |
ProMIS Neurosciences, Inc.
NASDAQ:PMN
Intrinsic Alpha fair value
Locked
Current Price
$11.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.